Table 3 |
||||||
|
Immunohistochemistry results of CK19 and Galectin-3 in papillary thyroid carcinoma (PTC) with or without lymphatic metastasis and other nonmalignant thyroid lesions |
||||||
|
nodular goiter n = 97 |
Follicular adenoma N = 54 |
PTC1 N = 248 |
PTC2 N = 193 |
|||
|
|
||||||
|
CK19 |
+ |
Female |
21(21.65) |
10(18.52) |
202(81.45) |
121(62.69) |
|
Male |
5(5.15) |
3(5.56) |
44(17.75) |
58(30.05) |
||
|
- |
Female |
52(53.61) |
30(55.56) |
0(0.00) |
8(4.15) |
|
|
Male |
19(19.59) |
11(20.36) |
2(0.80) |
6(3.11) |
||
|
Galectin |
+ |
Female |
37(38.15) |
19(35.19) |
196(79.03) |
122(63.21) |
|
Male |
14(14.43) |
7(12.96) |
45(18.14) |
64(33.16) |
||
|
- |
Female |
36(37.11) |
21(38.89) |
6(2.43) |
7(3.63) |
|
|
Male |
10(10.31) |
7(12.96) |
1(0.40) |
0(0.00) |
||
|
|
||||||
|
PTC1: papillary thyroid carcinoma (PTC) without lymphatic metastasis PTC2: papillary thyroid carcinoma (PTC) with lymphatic metastasis |
||||||
|
Song et al. Diagnostic Pathology 2011 6:126 doi:10.1186/1746-1596-6-126 |
||||||
